KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vertex Pharmaceuticals (VRTX) Minority Interest (2016 - 2018)

Historic Minority Interest for Vertex Pharmaceuticals (VRTX) over the last 8 years, with Q3 2018 value amounting to $28.4 million.

  • Vertex Pharmaceuticals' Minority Interest rose 13313.06% to $28.4 million in Q3 2018 from the same period last year, while for Sep 2018 it was $28.4 million, marking a year-over-year increase of 13313.06%. This contributed to the annual value of $13.7 million for FY2017, which is 9244.15% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Minority Interest of $28.4 million as of Q3 2018, which was up 13313.06% from $28.7 million recorded in Q2 2018.
  • Vertex Pharmaceuticals' Minority Interest's 5-year high stood at $196.0 million during Q2 2017, with a 5-year trough of $12.2 million in Q3 2017.
  • Its 5-year average for Minority Interest is $106.9 million, with a median of $153.5 million in 2015.
  • In the last 5 years, Vertex Pharmaceuticals' Minority Interest surged by 65486.98% in 2016 and then crashed by 9348.64% in 2017.
  • Over the past 5 years, Vertex Pharmaceuticals' Minority Interest (Quarter) stood at $21.2 million in 2014, then surged by 625.6% to $153.7 million in 2015, then grew by 18.19% to $181.6 million in 2016, then crashed by 92.44% to $13.7 million in 2017, then soared by 106.64% to $28.4 million in 2018.
  • Its Minority Interest stands at $28.4 million for Q3 2018, versus $28.7 million for Q2 2018 and $29.8 million for Q1 2018.